Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Guaraldi, Giovanni
NCT03696160 / 2018-003481-13: The Late Presenter Treatment Optimisation Study	Completed	3	447	Europe	Biktarvy, Symtuza	NEAT ID Foundation, Gilead Sciences, Janssen Pharmaceuticals	HIV/AIDS	06/24	06/24
PRECISION, NCT05926505 / 2023-000102-25: Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome	Recruiting	2/3	182	Europe	Placebo, Anakinra 149 MG/ML Prefilled Syringe [Kineret]	Hellenic Institute for the Study of Sepsis, Hellenic Institute for the Study of Sepsis	Post-Acute COVID-19 Syndrome, Post-Acute COVID-19, Long COVID	08/25	08/25
NCT05497089 / 2022-000618-32: Temelimab as a Disease Modifying Therapy in Patients With Neuropsychiatric Symptoms in Post-COVID 19 or PASC Syndrome	Completed	2	203	Europe	Temelimab 54mg/kg, Placebo	GeNeuro SA, GeNeuro S.A.	Post-COVID-19 Syndrome	05/24	05/24
Beghetto, Barbara
No trials found
Longo, Caterina
No trials found